Data as of 1:08pm ET
| +0.01 / +0.42%|
The 2 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +47.06% increase from the last price of 2.38.
The current consensus among 3 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.